Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive loss of motor neurons, muscle weakness, paralysis, and eventual death. The disease affects males and females differently. A key feature of ALS is immune system dysfunction in the central nervous system (brain and spinal cord) and outside, in peripheral blood. This study aims to study how immune cells in blood of ALS patients have altered gene expression (the extent to which genes are turned on) compared to healthy participants, with a focus on how biological sex contributes to these changes. We will collect blood samples from ALS patients and healthy individuals, and use advanced single-cell RNA sequencing technology to measure the gene expression pattern in thousands of individual cells. This approach allows us to identify specific immune cell types and pathways that may contribute to ALS progression, as well as differences between males and females with the disease. By addressing key questions about peripheral immune cell involvement in ALS, the project could contribute to better treatment and patient care, which directly support the missions of our partner organization, Alberta ALS Research Network (AARN). The project could also lead to new collaborations between researchers in the AARN network.
Gerald Pfeffer;Minh Dang Nguyen
Alberta ALS Research Network
Life Sciences
Health and Related Sciences & Technology
University of Calgary
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.